|
|
|
 |
| What we do | How to apply | About us | News | Events | Clients | Contact Us | | HOME | |
 |
 |
 |
 |
 |
 |
Latest News |
|
Chromatide to design polymers for stem cell research with the University of Liverpool - 26th February 2008  Picture shows: left to right Chromatide Founders: Saeed Gulzar and Don Wellings Chromatide is to work with the University of Liverpool on the development of new polymers for stem cell research. Stem cell research is considered vitally important in the research into potential cures of a range of debilitating diseases such as Alzheimer’s disease and diabetes. Chromatide is an IP-driven company backed by the Liverpool Seed Fund. The Company’s novel and proprietary encapsulation technologies will be used for stem cell culture and differentiation to facilitate stem cell research applications. The project has been enabled by the University of Liverpool Collaborative Awards in Science and Engineering (CASE studentship). The three year project with the School of Biological Sciences at the University of Liverpool is co-funded by the Biotechnology and Biological Sciences Research Council (BBSRC). This affiliation brings together Chromatide's considerable experience in novel polymer design and synthesis, with the considerable expertise of Professor Jerry Turnbull and Dr Patricia Murray in stem cell biology and cell signalling research. Professor Turnbull, from the University of Liverpool said, “ Our collaboration to develop novel polymers for use in stem cell cultures will enable us to quickly develop improved cell culture techniques”. Dr Don Wellings, Chromatide’s CSO, said, “We are delighted to be working with the University of Liverpool on this project. It illustrates how we are applying our proprietary technologies in a range of applications which are at the forefront of key life science research applications. The relationship is enabling us to combine our expertise in developing novel polymer technologies with the skills and knowledge that Professor Turnbull and Dr Murray have in this growing and exciting research area”. Chromatide has received investment from Merseyside Special Investment Fund’s Liverpool Seed Fund and RisingStars Growth Fund II and is supported by Malcolm Stewart of Liverpool Ventures a subsidiary of MSIF which provides advisory services post investment by the Liverpool Seed Fund. www.chromatide.com Ends For further information contact Gillian Hunt at Liverpool Ventures 0151 482 5533 *Alliance Fund Managers (AFM) is regulated by the FSA in the course of investment business Back to Previous
|
|
 |
 |
|
Liverpool Ventures
5th Floor, Cunard Building, Pier Head Liverpool L3 1DS Tel: 0151 236 0500 | 0151 236 4040 Fax: 0151 236 3060 email: info@liverpoolventures.com |
 |
 |